Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP414391.RAGVtu9miRYmr_r31a89DLS2vKQTUIXhcJj8bziHE6K98130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP414391.RAGVtu9miRYmr_r31a89DLS2vKQTUIXhcJj8bziHE6K98130_assertion type Assertion NP414391.RAGVtu9miRYmr_r31a89DLS2vKQTUIXhcJj8bziHE6K98130_head.
- NP414391.RAGVtu9miRYmr_r31a89DLS2vKQTUIXhcJj8bziHE6K98130_assertion description "[This study describes the use of DHPLC for mutation analysis for BRCA1, BRCA2 and CHEK2 (1100delC) in 22 patients with a family history of breast and/or ovarian cancer and early onset breast cancer (<35 years of age).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP414391.RAGVtu9miRYmr_r31a89DLS2vKQTUIXhcJj8bziHE6K98130_provenance.
- NP414391.RAGVtu9miRYmr_r31a89DLS2vKQTUIXhcJj8bziHE6K98130_assertion evidence source_evidence_literature NP414391.RAGVtu9miRYmr_r31a89DLS2vKQTUIXhcJj8bziHE6K98130_provenance.
- NP414391.RAGVtu9miRYmr_r31a89DLS2vKQTUIXhcJj8bziHE6K98130_assertion SIO_000772 14507240 NP414391.RAGVtu9miRYmr_r31a89DLS2vKQTUIXhcJj8bziHE6K98130_provenance.
- NP414391.RAGVtu9miRYmr_r31a89DLS2vKQTUIXhcJj8bziHE6K98130_assertion wasDerivedFrom befree-2016 NP414391.RAGVtu9miRYmr_r31a89DLS2vKQTUIXhcJj8bziHE6K98130_provenance.
- NP414391.RAGVtu9miRYmr_r31a89DLS2vKQTUIXhcJj8bziHE6K98130_assertion wasGeneratedBy ECO_0000203 NP414391.RAGVtu9miRYmr_r31a89DLS2vKQTUIXhcJj8bziHE6K98130_provenance.